
Bijal Parikh, MD, PhD
Assistant Professor, Pathology & Immunology
- Phone: 314-273-7926
- Email: bparikh@wustl.edu
Additional Titles
- Medical Director, Molecular Diagnostics Laboratory
- Associate Medical Director, Molecular Infectious Disease Laboratory
- Associate Medical Director, HLA Laboratory
- Director, Molecular Genetic Pathology Fellowship
Education
- BS: Rutgers University, New Brunswick, NJ (1998)
- PhD: Rutgers University, New Brunswick, NJ (2004)
- MD: Robert Wood Johnson Medical School-Rutgers University, Piscataway, NJ (2006)
- Residency, Clinical Pathology: Washington University, St. Louis, MO (2010)
- Fellowship, Molecular Genetic Pathology: Washington University, St. Louis, MO (2018)
Board Certifications
- Missouri Medical License
- American Board of Pathology in Clinical Pathology, 2011
- American Board of Pathology in Molecular Genetic Pathology, 2019
Recognition
-
Outstanding Research Award in Molecular Pathology/Pharmacogenomics, American Association for Clinical Chemistry Annual Meeting, 2009
-
Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists Annual Meeting, 2009, 2010
-
Infectious Diseases Training Grant (T32-A1007172), 2010
-
Rheumatology Training Grant (T32-AR007279), 2011-2012
-
Chair’s Special Recognition Award, COVID Clinical Hero, Washington University Department of Pathology and Immunology, 2020
-
Outstanding Achievements in Quality Improvement Award, Washington University Department of Pathology and Immunology, 2020
Research Interests
My clinical research centers on aspects of laboratory testing involving viral, immunologic, and molecular diagnostics, with a specific focus on the implementation of next-generation sequencing approaches. My basic science interests explore mechanisms governing host-pathogen interactions with ongoing research projects around the development of a murine cytomegalovirus model study innate immune control by natural killer cells and trafficking of virus during neonatal infection.
Publications
Selected Publications:
Raju S., Anderson N.W., Robinson E., Squires C., Wallace M.A., Burnham C.D, and Parikh B.A. Comparison of Six SARS-CoV-2 Molecular Methods and Correlation with the Cycle Threshold Distribution in Clinical Specimens. J Appl Lab Med. 2021 Jul 20:jfab086. |
Parikh, B.A. and Farnsworth W.C. Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic. Best Pract Res Clin Rheumatol, 2021. 101660. doi: 10.1016/j.berh.2021.101660. PMID: 33518410 |
Tahan S., Parikh B.A., Droit L, Wallace M., Burnham C.D., and Wang D. SARS-CoV-2 E gene variant alters analytical sensitivity characteristics of viral detection using a commercial RT-PCR assay. J. Clin. Microbiol. 2021. 59(7):e0007521. PMID: 33903167 |
Parikh B.A., Bern M.D., Piersma S.J., Yang L., Beckman D.L., Poursine-Laurent J., Plougastel-Douglas B., and Yokoyama W.M. Control of viral infection by natural killer cell inhibitory receptors. Cell Rep. 2020. 32:107969. PMID: 32726632 |
Parikh B.A., Love-Gregory L., Duncavage E.J., and Heusel J.W. Identification of challenges and a framework for implementation of the AMP/ASCO/CAP classification guidelines for reporting somatic variants. 2020. Pract Lab Med. 21:e00170. PMID: 32548229 |
Liu C., Duffy B.F., Weimer E.T., Montgomery M.C., Jennemann J.E., Hill R., Phelan D., Lay L., Parikh B.A. Performance of a multiplexed amplicon-based next-generation sequencing assay for HLA typing. PLoS One. 2020;15:e0232050. PMID: 32324777 |
Parikh B.A., Piersma S.J., Pak-Wittel M.A., Yang L., Schreiber R.D., and Yokoyama W.M. Dual requirement of cytokine and activation receptor triggering for cytotoxic control of murine cytomegalovirus by NK cells. PLoS Pathog. 2015 11:e1005323. PMID: 26720279 |
Parikh, B.A., Beckman, D.L., Patel, S.J., White, J.M., and Yokoyama, W.M. Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One. 2015; 10:e0116484. PMID: 25587897 |
Assistant
Christine Berry
314-362-2207
berryc@wustl.edu
Office Location: LGM, Suite 5806